The LOOXSTER® Effect
VYOO® achieves exceptional sensitivity through SIRS-Lab’s proprietary PUREPROVE® technology that concentrates bacterial and fungal DNA.Fast and Precise Results
Within 6 hours, VYOO®
detects 40 bacterial and fungal species that cause life-threatening
infections. In the same process, important antibiotic resistances are
identified. The system is unaffected by antibiotic pre-treatment and
starts directly from up to 5 ml whole blood samples.
Guided Antibiotic Therapy
VYOO®
carries a significant potential to guide antibiotic therapy in the
early therapeutic window. That determines the course and prognosis of
the septic patient. Moreover, the high utility of the sepsis test helps to safely
deescalate antibiotic therapy.
Simple Handling
VYOO® can smoothly be integrated in the workflow by using standard PCR equipment. The robust technology drastically reduces the liability for contamination. No special training is required.Technical Validity
- Validation by external clinicians and clinical microbiologists
- Design of more than 20,000 primer pairs
- Development of more than 1000 PCR assays
- Technical validation in more than 150,000 separate reactions
The Sepsis Test
drastically cuts costs per result by more aimed use of
antibiotics and shorter treatment time. VYOO® further reduces the emergence of resistant micro-organisms.
![[Keine Beschreibung eingegeben]](/files/vyoo_image.jpg)






- 538 kB
